PTEN and cancer: We then wanted to determine if these two distinctions between deletions affecting A2BP1 and MACROD2 loci on the one hand and CDKN2A/B and PTEN loci on the other hand held true when comparing deletions affecting known common fragile sites and recessive tumor suppressor genes from the Cancer Gene Census [20], [21].